On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Daniel Morgensztern

ResearcherPublications, citations & collaboration network

Daniel Morgensztern is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Daniel Morgensztern have?

ScholarIQindexed works

Daniel Morgensztern has 462 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Daniel Morgensztern have?

ScholarIQcitation count

Daniel Morgensztern has 21,067 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Daniel Morgensztern?

ScholarIQh-index

Daniel Morgensztern has an h-index of 51 in OpenAlex.

What is the i10-index of Daniel Morgensztern?

ScholarIQi10-index

Daniel Morgensztern has an i10-index of 141 in OpenAlex.

What is the ORCID of Daniel Morgensztern?

ScholarIQorcid

The ORCID for Daniel Morgensztern is on the source record.

What is the OpenAlex record for Daniel Morgensztern?

ScholarIQopenalex

The OpenAlex for Daniel Morgensztern is on the source record.

What are the most-cited papers on Daniel Morgensztern?

ScholarIQmost cited works
Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results Database
Ramaswamy Govindan, Nathan Page, Daniel Morgensztern, William L. Read, Ryan M. Tierney, Anna Vlahiotis, Edward L. Spitznagel, Jay F. Piccirillo
Journal of Clinical Oncology. 20061,859 CitationsOPEN ACCESS
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Malcolm M. DeCamp, Thomas J. Dilling, Jonathan E. Dowell, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aparna Hegde, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Jose M. Pacheco, Sandip Pravin Patel, Gregory J. Riely, Jonathan W. Riess, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, Miranda Hughes
Journal of the National Comprehensive Cancer Network. 20221,440 Citations
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Thomas J. Dilling, Jonathan E. Dowell, Scott Gettinger, Matthew A. Gubens, Aparna Hegde, Mark Hennon, Rudy P. Lackner, Michael Lanuti, Ticiana Leal, Jules Lin, Billy W. Loo, Christine M. Lovly, Renato Martins, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Sandip Pravin Patel, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Jane Yanagawa, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes
Journal of the National Comprehensive Cancer Network. 20211,015 CitationsOPEN ACCESS
Non–Small Cell Lung Cancer, Version 4.2024
Gregory J. Riely, Douglas E. Wood, David S. Ettinger, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Malcolm M. DeCamp, Aakash Desai, Thomas J. Dilling, Jonathan E. Dowell, Gregory A. Durm, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aditya Juloori, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Trey C. Mullikin, Thomas Ng, Dawn Owen, Dwight H. Owen, Sandip Pravin Patel, Tejas Patil, Patricio M. Polanco, Jonathan W. Riess, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, Lisa Hang
Journal of the National Comprehensive Cancer Network. 2024800 Citations
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study
Charles M. Rudin, M. Catherine Pietanza, Todd M. Bauer, Neal Ready, Daniel Morgensztern, Bonnie S. Glisson, Lauren A. Byers, Melissa L. Johnson, Howard A. Burris, Francisco Robert, Tae Hyung Han, Sheila Bheddah, Noah Theiss, Sky Watson, Deepan Mathur, Bharathi Vennapusa, Hany Zayed, Satwant Lally, Donald K. Strickland, Ramaswamy Govindan, Scott J. Dylla, Stanford L. Peng, David R. Spigel
The Lancet Oncology. 2016563 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account